Longboard Pharmaceuticals Stock Operating Margin
| LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Longboard Pharmaceuticals fundamentals help investors to digest information that contributes to Longboard Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Longboard Stock. The fundamental analysis module provides a way to measure Longboard Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Longboard Pharmaceuticals stock.
Longboard |
Longboard Pharmaceuticals Company Operating Margin Analysis
Longboard Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Longboard Pharmaceuticals has an Operating Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Longboard Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Longboard Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Longboard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics of similar companies.Longboard Pharmaceuticals is currently under evaluation in operating margin category among its peers.
Longboard Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 2.06 B | ||||
| Shares Outstanding | 34.44 M | ||||
| Shares Owned By Insiders | 1.19 % | ||||
| Shares Owned By Institutions | 98.81 % | ||||
| Number Of Shares Shorted | 1.93 M | ||||
| Price To Book | 8.51 X | ||||
| EBITDA | (56.75 M) | ||||
| Net Income | (54.42 M) | ||||
| Cash And Equivalents | 87.42 M | ||||
| Cash Per Share | 5.09 X | ||||
| Total Debt | 475 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 11.95 X | ||||
| Book Value Per Share | 7.05 X | ||||
| Cash Flow From Operations | (50.87 M) | ||||
| Short Ratio | 1.27 X | ||||
| Earnings Per Share | (2.25) X | ||||
| Target Price | 64.0 | ||||
| Number Of Employees | 50 | ||||
| Beta | 1.09 | ||||
| Market Capitalization | 2.34 B | ||||
| Total Asset | 50.7 M | ||||
| Retained Earnings | (140.56 M) | ||||
| Working Capital | 40.45 M | ||||
| Net Asset | 50.7 M |
About Longboard Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Longboard Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longboard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longboard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |